BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 30389496)

  • 1. Mitochondrial superoxide generation induces a parkinsonian phenotype in zebrafish and huntingtin aggregation in human cells.
    Pinho BR; Reis SD; Hartley RC; Murphy MP; Oliveira JMA
    Free Radic Biol Med; 2019 Jan; 130():318-327. PubMed ID: 30389496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective superoxide generation within mitochondria by the targeted redox cycler MitoParaquat.
    Robb EL; Gawel JM; Aksentijević D; Cochemé HM; Stewart TS; Shchepinova MM; Qiang H; Prime TA; Bright TP; James AM; Shattock MJ; Senn HM; Hartley RC; Murphy MP
    Free Radic Biol Med; 2015 Dec; 89():883-94. PubMed ID: 26454075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced mitochondrial complex II activity enhances cell death via intracellular reactive oxygen species in STHdhQ111 striatal neurons with mutant huntingtin.
    Okada N; Yako T; Nakamura S; Shimazawa M; Hara H
    J Pharmacol Sci; 2021 Dec; 147(4):367-375. PubMed ID: 34663519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin and IGF-1 improve mitochondrial function in a PI-3K/Akt-dependent manner and reduce mitochondrial generation of reactive oxygen species in Huntington's disease knock-in striatal cells.
    Ribeiro M; Rosenstock TR; Oliveira AM; Oliveira CR; Rego AC
    Free Radic Biol Med; 2014 Sep; 74():129-44. PubMed ID: 24992836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Downregulation of glial genes involved in synaptic function mitigates Huntington's disease pathogenesis.
    Onur TS; Laitman A; Zhao H; Keyho R; Kim H; Wang J; Mair M; Wang H; Li L; Perez A; de Haro M; Wan YW; Allen G; Lu B; Al-Ramahi I; Liu Z; Botas J
    Elife; 2021 Apr; 10():. PubMed ID: 33871358
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Compartmentalized oxidative stress in dopaminergic cell death induced by pesticides and complex I inhibitors: distinct roles of superoxide anion and superoxide dismutases.
    Rodriguez-Rocha H; Garcia-Garcia A; Pickett C; Li S; Jones J; Chen H; Webb B; Choi J; Zhou Y; Zimmerman MC; Franco R
    Free Radic Biol Med; 2013 Aug; 61():370-83. PubMed ID: 23602909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Auraptene Mitigates Parkinson's Disease-Like Behavior by Protecting Inhibition of Mitochondrial Respiration and Scavenging Reactive Oxygen Species.
    Jang Y; Choo H; Lee MJ; Han J; Kim SJ; Ju X; Cui J; Lee YL; Ryu MJ; Oh ES; Choi SY; Chung W; Kweon GR; Heo JY
    Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31336718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitochondrial and Redox-Based Therapeutic Strategies in Huntington's Disease.
    Fão L; Rego AC
    Antioxid Redox Signal; 2021 Mar; 34(8):650-673. PubMed ID: 32498555
    [No Abstract]   [Full Text] [Related]  

  • 9. Conophylline protects cells in cellular models of neurodegenerative diseases by inducing mammalian target of rapamycin (mTOR)-independent autophagy.
    Sasazawa Y; Sato N; Umezawa K; Simizu S
    J Biol Chem; 2015 Mar; 290(10):6168-78. PubMed ID: 25596530
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential for therapeutic use of hydrogen sulfide in oxidative stress-induced neurodegenerative diseases.
    Tabassum R; Jeong NY
    Int J Med Sci; 2019; 16(10):1386-1396. PubMed ID: 31692944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitochondrial DNA damage is associated with reduced mitochondrial bioenergetics in Huntington's disease.
    Siddiqui A; Rivera-Sánchez S; Castro Mdel R; Acevedo-Torres K; Rane A; Torres-Ramos CA; Nicholls DG; Andersen JK; Ayala-Torres S
    Free Radic Biol Med; 2012 Oct; 53(7):1478-88. PubMed ID: 22709585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Restoration of c-Src/Fyn Proteins Rescues Mitochondrial Dysfunction in Huntington's Disease.
    Fão L; Coelho P; Duarte L; Vilaça R; Hayden MR; Mota SI; Rego AC
    Antioxid Redox Signal; 2023 Jan; 38(1-3):95-114. PubMed ID: 35651273
    [No Abstract]   [Full Text] [Related]  

  • 13. Mitochondrial SIRT3 confers neuroprotection in Huntington's disease by regulation of oxidative challenges and mitochondrial dynamics.
    Naia L; Carmo C; Campesan S; Fão L; Cotton VE; Valero J; Lopes C; Rosenstock TR; Giorgini F; Rego AC
    Free Radic Biol Med; 2021 Feb; 163():163-179. PubMed ID: 33285261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Olesoxime suppresses calpain activation and mutant huntingtin fragmentation in the BACHD rat.
    Clemens LE; Weber JJ; Wlodkowski TT; Yu-Taeger L; Michaud M; Calaminus C; Eckert SH; Gaca J; Weiss A; Magg JC; Jansson EK; Eckert GP; Pichler BJ; Bordet T; Pruss RM; Riess O; Nguyen HP
    Brain; 2015 Dec; 138(Pt 12):3632-53. PubMed ID: 26490331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxidizing effects of exogenous stressors in Huntington's disease knock-in striatal cells--protective effect of cystamine and creatine.
    Ribeiro M; Silva AC; Rodrigues J; Naia L; Rego AC
    Toxicol Sci; 2013 Dec; 136(2):487-99. PubMed ID: 24008831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mitochondrial permeability transition pore induces mitochondria injury in Huntington disease.
    Quintanilla RA; Jin YN; von Bernhardi R; Johnson GV
    Mol Neurodegener; 2013 Dec; 8():45. PubMed ID: 24330821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessing Mitochondrial Function in In Vitro and Ex Vivo Models of Huntington's Disease.
    Ferreira IL; Carmo C; Naia L; I Mota S; Cristina Rego A
    Methods Mol Biol; 2018; 1780():415-442. PubMed ID: 29856029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective mitochondrial superoxide generation in vivo is cardioprotective through hormesis.
    Antonucci S; Mulvey JF; Burger N; Di Sante M; Hall AR; Hinchy EC; Caldwell ST; Gruszczyk AV; Deshwal S; Hartley RC; Kaludercic N; Murphy MP; Di Lisa F; Krieg T
    Free Radic Biol Med; 2019 Apr; 134():678-687. PubMed ID: 30731114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Visualization of prion-like transfer in Huntington's disease models.
    Jansen AH; Batenburg KL; Pecho-Vrieseling E; Reits EA
    Biochim Biophys Acta Mol Basis Dis; 2017 Mar; 1863(3):793-800. PubMed ID: 28040507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fibroblast growth factor 9 activates anti-oxidative functions of Nrf2 through ERK signalling in striatal cell models of Huntington's disease.
    Yusuf IO; Chen HM; Cheng PH; Chang CY; Tsai SJ; Chuang JI; Wu CC; Huang BM; Sun HS; Yang SH
    Free Radic Biol Med; 2019 Jan; 130():256-266. PubMed ID: 30391672
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.